Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Encompass Health (EHC) one of those stocks right now? A

Is Shinhan Financial Group Co (SHG) Stock Undervalued Right Now?
Is Shinhan Financial Group Co (SHG) Stock Undervalued Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Down 10.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Marex Group PLC (MRX)
Down 10.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Marex Group PLC (MRX)

Marex Group PLC (MRX) has been on a downward spiral lately with significant selling pressure. After declining 10.8% over the past four weeks, the stock looks well positioned for a trend reversal as

After Plunging 14.2% in 4 Weeks, Here's Why the Trend Might Reverse for Accel Entertainment (ACEL)
After Plunging 14.2% in 4 Weeks, Here's Why the Trend Might Reverse for Accel Entertainment (ACEL)

A downtrend has been apparent in Accel Entertainment (ACEL) lately with too much selling pressure. The stock has declined 14.2% over the past four weeks. However, given the fact that it is now in

IREN Limited (IREN) Just Flashed Golden Cross Signal: Do You Buy?
IREN Limited (IREN) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, IREN Limited (IREN) is looking like an interesting pick, as it just reached a key level of support. IREN recently overtook the 20-day moving average, and this suggests

After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST)
After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST)

Twist Bioscience (TWST) has been beaten down lately with too much selling pressure. While the stock has lost 33.8% over the past four weeks, there is light at the end of the tunnel as it is now in

Down 10.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Nomad Foods (NOMD)
Down 10.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Nomad Foods (NOMD)

Nomad Foods (NOMD) has been beaten down lately with too much selling pressure. While the stock has lost 10.7% over the past four weeks, there is light at the end of the tunnel as it is now in

Down 15.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Kennametal (KMT)
Down 15.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Kennametal (KMT)

Kennametal (KMT) has been on a downward spiral lately with significant selling pressure. After declining 15.3% over the past four weeks, the stock looks well positioned for a trend reversal as it is

Jackson Financial (JXN) Crossed Above the 20-Day Moving Average: What That Means for Investors
Jackson Financial (JXN) Crossed Above the 20-Day Moving Average: What That Means for Investors

Jackson Financial (JXN) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, JXN crossed above the 20-day moving average

Kenvue (KVUE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Kenvue (KVUE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Kenvue (KVUE) reported $3.84 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 4%. EPS of $0.29 for the same period compares to $0.32 a year ago.

The

Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Prestige Consumer Healthcare (PBH) reported $249.53 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 6.6%. EPS of $0.95 for the same period compares to

Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Viatris (VTRS) reported revenue of $3.58 billion, down 5.7% over the same period last year. EPS came in at $0.62, compared to $0.69 in the year-ago quarter.

The

Haemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say
Haemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say

Haemonetics (HAE) reported $321.39 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 4.4%. EPS of $1.10 for the same period compares to $1.02 a year ago.

ConocoPhillips (COP) Reports Q2 Earnings: What Key Metrics Have to Say
ConocoPhillips (COP) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, ConocoPhillips (COP) reported revenue of $14.74 billion, up 4.3% over the same period last year. EPS came in at $1.42, compared to $1.98 in the year-ago quarter.

The

Canadian Natural Resources (CNQ) Reports Q2 Earnings: What Key Metrics Have to Say
Canadian Natural Resources (CNQ) Reports Q2 Earnings: What Key Metrics Have to Say

Canadian Natural Resources (CNQ) reported $6.29 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 5%. EPS of $0.51 for the same period compares to $0.64 a

Insmed (INSM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Insmed (INSM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, Insmed (INSM) reported revenue of $107.42 million, up 18.9% over the same period last year. EPS came in at -$1.70, compared to -$1.94 in the year-ago quarter.

The

Maximus (MMS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Maximus (MMS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, Maximus (MMS) reported revenue of $1.35 billion, up 2.6% over the same period last year. EPS came in at $2.16, compared to $1.74 in the year-ago quarter.

The

Compared to Estimates, CDW (CDW) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, CDW (CDW) Q2 Earnings: A Look at Key Metrics

CDW (CDW) reported $5.98 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.2%. EPS of $2.60 for the same period compares to $2.50 a year ago.

The

Acushnet (GOLF) Reports Q2 Earnings: What Key Metrics Have to Say
Acushnet (GOLF) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Acushnet (GOLF) reported revenue of $720.48 million, up 5.4% over the same period last year. EPS came in at $1.25, compared to $1.11 in the year-ago quarter.

The

Restaurant Brands (QSR) Reports Q2 Earnings: What Key Metrics Have to SayPhoto, wide shot, wide-angle lens,  Clothing manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/7d69264d-49b2-466c-9987-b2706836d522.png
Restaurant Brands (QSR) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Restaurant Brands (QSR) reported revenue of $2.41 billion, up 15.9% over the same period last year. EPS came in at $0.94, compared to $0.86 in the year-ago quarter.

Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key MetricsPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics

Collegium Pharmaceutical (COLL) reported $188 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 29.4%. EPS of $1.68 for the same period compares to $1.62

Compared to Estimates, Martin Marietta (MLM) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Martin Marietta (MLM) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Martin Marietta (MLM) reported revenue of $1.81 billion, up 2.7% over the same period last year. EPS came in at $5.43, compared to $5.26 in the year-ago quarter.

The

Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q3 Earnings
Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q3 Earnings

Becton Dickinson (BDX) reported $5.51 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.4%. EPS of $3.68 for the same period compares to $3.50 a year

Playtika (PLTK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Playtika (PLTK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Playtika Holding (PLTK) reported $696 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 11%. EPS of $0.02 for the same period compares to $0.23 a year

PENN Entertainment (PENN) Reports Q2 Earnings: What Key Metrics Have to Say
PENN Entertainment (PENN) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, PENN Entertainment (PENN) reported revenue of $1.77 billion, up 6.1% over the same period last year. EPS came in at $0.10, compared to -$0.18 in the year-ago